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Adenocarcinoma and squamous cell carcinoma account for the vast majority of oesophageal malignancies. Other malignancies
known to occur in the oesophagus include melanoma, sarcoma, and lymphoma. Among the sarcomas, carcinosarcoma is the
commonest with both carcinomatous and sarcomatous elements followed by leiomyosarcoma of mesenchymal origin. Other
sarcomas reported in the literature are liposarcoma, synovial sarcoma, myxoﬁbrosarcoma, Ewing’s sarcoma, granulocytic sarcoma,
histiocyticsarcoma,schwannoma rhabdomyosarcoma, andepithelioidsarcoma. Wereport acase ofmalignant spindlecell tumour
of oesophagus. Sarcomas of esophagus present as a polypoid exophytic soft tissue mass. Our patient presented with a stricture
which is a rare presentation. Locally aggressive treatment with surgery is beneﬁcial, and local palliative treatment including
radiotherapy is worthwhile.
1.Introduction
Ninety-ﬁve percentofesophagealmalignancies are ofepithe-
lial origin: adenocarcinoma and squamous cell carcinoma
[1]. Sarcomas are a rare entity along with melanoma and
lymphoma. Varied histologies of sarcomas are reported
such as carcinosarcoma (both epithelial and mesenchy-
mal elements), leiomyosarcoma [2], synovial sarcoma [3],
myxoﬁbrosarcoma [4], Ewing’s sarcoma [5], granulocytic
sarcoma [6], histiocytic sarcoma [7], schwannoma [8],
rhabdomyosarcoma [9], and epithelioid sarcoma. Sarcomas
present as an exophytic polypoidal mass. We present a case
ofstrictureesophagusturnedouttobemalignantspindlecell
tumor.
2.CaseReport
Sixty-three-year-old man who was a dentist by profession
from West Bengal presented in March 2005 with complaints
of dysphagia to solids for 12yrs aggravated for 1 month. He
had no loss of appetite but had loss of weight. His physical
examination wasunremarkable. Uppergastroesophagoscopy
revealed a smooth, benign appearing stricture at 36cm
beyond which the mucosa was normal. There was a 1.5cm
diameter smooth mucosal bulge noted in the fundus of the
stomach just beyond the gastroesophageal (GE) junction.
Biopsy form of the bulge was taken and was reported as mild
chronic gastritis with Helicobacter pylori infestation. He was
treated with proton pump inhibitors for six weeks.
The dysphagia worsened within a span of ten months,
and repeat endoscopy revealed a stricture at the same
place. Biopsy was not suggestive of malignancy. Barium
swallow revealed dilated thoracic esophagus with smooth
tapered narrowing (Figure 1). CT scan was done which
revealed a lower esophageal wall thickening of 11mm
from T9 to GE junction (Figure 2) with periesophageal
soft tissue mass and periesophageal, lesser omental, and
peripancreatic nodes along with left pleural eﬀusion and
adjacent lung atelectasis. Pleural ﬂuid cytology and pleural
biopsy did not show any evidence of malignancy. He was
planned for stricture resection and exploratory laparotomy.
Peroperatively, lower esophageal thickening was noted and
a large, friable, periesophageal tumour mass extending
along the crus of the diaphragm involving the coeliac
nodes was found. There were multiple enlarged friable
ﬂeshy nodes. Multiple biopsies were taken from the perioe-
sophageal tissue and nodal mass, and feeding jejunostomy
was done. Histopathologically, ﬁbroadipose tissue with a
cellular tumour composed of fascicles of spindle shaped2 Case Reports in Gastrointestinal Medicine
Figure 1
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cells with plump oval to elongated, moderately pleomorphic,
mitotically active nuclei (4-5 per 10 high power ﬁelds) was
found (Figure 3). Many haemosiderophages, foci of recent
haemorrhage, hyalinization, and congestion were present;
the tumor was focally positive for Vimentin and was negative
for SMA, CD 34, CAM 5.2, cytokeratin, desmin, S100, and
CD 117. Hence, a diagnosis of malignant spindle cell tumor
with sarcoma being a possibility was made.
After literature search, the decision was made to treat as
sarcoma esophagus with palliative intent as no formal proto-
cols were available. He received radiation therapy of 46Gy in
23 fractions by AP-PA portals using Telecobalt machine. CT
scan done 6 weeks after radiotherapy showed stable disease.
He received 4cycles of chemotherapy with Doxorubicin
(50mg/m2,Day1)andIfosfamide(5000mg/m2,Day1)given
at 3 weekly intervals. Third cycle was given at a delayed
date with reduced dose due to earlier neutropenic sepsis and
herpes zoster.
Repeat CT scan after 4 cycles of chemotherapy showed
stable disease. In view of hematological toxicities he had, fur-
ther chemotherapy was not given. The patient was explained
regarding further options—continuing chemotherapy with
Figure 3
increased risk of side eﬀects and lesser response rate versus
best supportive care, and he opted for best supportive care.
Endoscopic stenting was done as palliation. He expired
after six months at hometown due to stent blockage or
gastrointestinal obstruction beyond the stent. He has had a
survival of 20months from the time of diagnosis with a good
quality of life without dysphagia.
3. Discussion
3.1. Epidemiology and Incidence. Esophageal sarcomas are
a rare entity [7]. Morphological variants of esophageal
sarcomas as reported in the literature are summarized in
Table 1.
3.2. Clinical Features. The median age at diagnosis for
esophageal sarcoma is 58years [26–76years] [17]. Usually
patients present with progressive dysphagia [18], weight loss
[18], chest discomfort [19], burning retrosternal pain [20],
nausea, and vomiting [20].
3.3. Diagnosis. Endoscopically, these are characterized by
polypoid and exophytic masses [21] and rarely as ulcerating
tumour [22]. Barium studies may show large intramu-
ral mass with ulceration/tracking, expansile intraluminal
masses, or areas of luminal narrowing [23]. Stricture esoph-
agus is a rare presentation. CT/MRI imaging may show
inhomogenously enhancing intramural mass [23]. One of
the indications for endoscopic ultrasound and its guided
biopsy or ﬁne needle aspiration cytology is submucosal
esophageal tumors which otherwise may need open biopsy
for diagnosis. This in turn may reduce the time of delay in
diagnosis [24].
3.4. Pathology. Considering histological appearance and
immunohistochemistry of sarcomas of esophagus, carci-
nosarcomas has both carcinomatous and sarcomatous com-
ponent. The sarcomatous component of carcinosarcoma is
composed of dense interlacing bundles of spindle-shaped
cells in the submucosa [25].Case Reports in Gastrointestinal Medicine 3
Table 1: Morphological variants of esophageal sarcoma.
Type Immunohistochemistry Incidence (among
esophageal cancer) Survival Reference
1. Carcinosarcoma Positive for cytokeratin, vimentin,
smooth muscle actin, and p53 [10] Approximately 6% DFS∗ of 45 months Nakagawa et al., [11]
2. Leiomyosarcoma Strongly positive for SMA, negative
for cytokeratin [12] 0.5% DFS∗ of 14 months,
survival of 20 months Adad et al., [12]
3. Liposarcoma Positive only for S100 Very rare; nearly 13
to 15 reported cases N o tm e n t i o n e d G a r c i ae ta l . ,[ 13]
4. Synovial sarcoma
Biphasic morphologic ﬁndings
positive for vimentin, epithelial
(EMA, CK7, AE1/3), bcl-2, and
neuroectodermal (CD56, CD57,
CD99)X;18 translocation on FISH
[14]
Very rare; nearly 10
cases reported Not known Butori et al., [15]
5. Myxoﬁbrosarcoma
Positive for CD34, smooth muscle
actin, negative for S-100, C-kit, and
desmin [4]
Very rare; 1 to 2
cases reported Not known Song and Miller, [4]
6. Ewing’s sarcoma MIC2/CD99 positive Very rare; 1 to 2
cases reported N o tk n o w n M a e s a w ae ta l . ,[ 5]
7.Granulocytic sarcoma Subepithelial dense deposits of
myeloid cells histologically Very rare Not mentioned Ibrarullah et al., [6]
8.Histiocytic sarcoma
Positive for CD68 and negative for
CD1a and CD35, negative for Ki-1
antigen and T-cell and B-cell
lineage markers [7]
Very rare 1 month Akishima et al., [7]
9. Schwannoma Positive for S100 and vimentin;
negative for CD117 Very rare Not known Sanchez et al., [8]
10. Rhabdomyosarcoma Intracytoplasmic cross striations
histologically
Very rare;15
reported cases Not known Batoroev and Nguyen,
[9]
11. Epithelioid sarcoma
Positive for both epithelial and
mesenchymal markers, such as
cytokeratin, epithelial membrane
antigen (EMA), vimentin and CD34
Very rare Not mentioned Maggiani et al., [16]
∗disease-free survival.
Pseudosarcoma shows squamous cell carcinoma and
mesenchymal components without a transitional zone [19].
Synovial sarcoma has undiﬀerentiated spindle cells sim-
ilar in appearance to synovial sarcoma in other areas but
overt mesenchymal diﬀerentiation showing smooth muscle,
cartilage,orboneformation.X;18translocationisasensitive
marker and is demonstrated in 70 to 90% of synovial
sarcomas. The speciﬁc t(X; 18) (p11.2; q11.2) results in the
fusion gene product SYT-SSX [14].
Leiomyosarcoma has elongated cells forming interlaced
bundles. Leiomyosarcoma constitutes about 0.5% of the
malignant neoplasms of the oesophagus [12]. Oesophageal
leiomyosarcoma possibly arises from the muscularis mucosa
[3].
Liposarcoma has the lipogenic component containing
giant multinucleated lipoblasts with multiple cytoplasmic
lipid vacuoles giving grape-like appearance. The nonli-
pogenic component can resemble pleomorphic and/or myx-
oid MFH expansion of Malignant Fibrous Histiocytoma,
a round cell sarcoma, a spindle liposarcoma, and/or an
epithelioid carcinoma [13].
Histiocytic sarcoma has medium-sized tumor cells,
indistinguishable from reactive histiocytes with moderate
pleomorphism.
The tumor in our case was unique in that it did not
have carcinomatous component and it was focally positive
for Vimentin not making it any of the above-mentioned
sarcomas of esophagus.
3.5.Treatment. Surgery,whereverpossible,remainstobethe
mainstay of treatment [23]. Oesophagectomy/oesophago-
gastrectomy is the surgery of choice. Even if metastases are
present, a palliative resection can still be performed [26].
Endoscopic resection is another surgical option available
[27]. The role of adjuvant radiotherapy and chemotherapy
is controversial [23]. Palliative procedures like stenting to
relieve dysphagia improve quality of life [28].
3.6. Prognostic Factors. Factors aﬀecting survival included
completenessofresection,growthpattern,postsurgicalstage,
tumour grade, and tumour location [18]. A rare case of
spontaneous regression of oesophageal leiomyosarcoma is
reported [29]. The more favourable prognosis associated
with carcinosarcoma versus other oesophageal neoplasms
has been attributed to early onset of symptoms, resulting
in prompt diagnosis and a lower propensity for tumour
invasion [30]. As in typical squamous cell carcinoma, early4 Case Reports in Gastrointestinal Medicine
detection and treatment by surgical resection are needed to
produce signiﬁcant long-term survival [31].
3.7.ThePresentCaseintheContextoftheLiterature. Sarcoma
isarareentityamongallesophagealmalignancies.Itpresents
as an exophytic mass, and in this case, it has presented as a
stricture esophagus. Most of these tumors present in locally
advanced and disseminated condition, one of the reasons
being diﬃculty and hence delay in diagnosis. Inspite of best
eﬀorts, a group among them remains to be histologically
uncharacterized. Here, we report a case of malignant spindle
cell tumor of esophagus, a cause for a stricture esophagus. A
deﬁnitive histopathological diagnosis could not be achieved.
Regarding treatment, there is a role of palliative resection
even in case of inoperable disease. In view of locoregional
failure, the role of aggressive local treatment should be
emphasized.
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